|
|
||||||||
The Annals of Thoracic Surgery, Vol 57, 611-614, Copyright © 1994 by The Society of Thoracic Surgeons
JM Pearl, H Laks, S Barthell, DC Drinkwater Jr, ER Capouya and PA Chang
The concept of the partial Fontan procedure, first described with the
adjustable atrial septal defect (ASD) and more recently with the
fenestrated technique, has become an accepted approach for the management
of high-risk patients undergoing the Fontan procedure. Experience with both
techniques has shown that a patent ASD placed in a prosthetic interatrial
baffle may close spontaneously over a period of weeks to months. The
mechanism and timing of spontaneous closure, as well as the effect of
antiplatelet therapy on this process, are poorly understood. To better
define this process, the interatrial septum of 15 mongrel dogs was excised
and replaced with a fenestrated Gore-Tex (W.L. Gore, Flagstaff, AZ) patch.
Postoperative echocardiography confirmed the patency of the ASD and
left-to-right shunting. Animals were sacrificed 4 to 6 weeks
postoperatively, or sooner if infection or other postoperative
complications developed. Eight animals underwent no antiplatelet or
anticoagulation therapy postoperatively, and 7 received antiplatelet
therapy with aspirin. Patches were removed at the end of the study period
and analyzed. By 6 weeks, all 2.7-mm and 4-mm holes had closed
spontaneously in all animals that had not received antiplatelet therapy.
The earliest closure occurred at 1 week. With antiplatelet therapy, hole
closure was found to be delayed but not prevented, and was complete by 6
weeks in all but 1 animal. Histologic examination of the explanted patches
revealed that closure was accomplished primarily through the ingrowth of
fibrous tissue, accompanied by an inflammatory cell infiltrate.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Spontaneous closure of fenestrations in an interatrial Gore-Tex patch: application to the Fontan procedure
Department of Surgery, University of California, Los Angeles Medical School.
This article has been cited by other articles:
![]() |
M. Pawelec-Wojtalik, J. Nozynski, M. Wojtalik, M. Piaszczynski, R. Surmacz, D. Bukowska, and W. Mrowczynski Is device closure for direct access valved stent implantation safe? Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 4 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kaulitz, G. Ziemer, T. Paul, M. Peuster, H. Bertram, and G. Hausdorf Fontan-type procedures: residual lesions and late interventions Ann. Thorac. Surg., September 1, 2002; 74(3): 778 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Jacobs, K. K. Pourmoghadam, E. M. Geary, A. T. Reyes, N. Madan, L. B. McGrath, and J. W. Moore Fontan's operation: is aspirin enough? Is coumadin too much? Ann. Thorac. Surg., January 1, 2002; 73(1): 64 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Tofeig, K P Walsh, C Chan, E Ladusans, G Gladman, and R Arnold Occlusion of Fontan fenestrations using the Amplatzer septal occluder Heart, April 1, 1998; 79(4): 368 - 370. [Abstract] [Full Text] |
||||
![]() |
J. Rychik, J. J. Rome, and M. L. Jacobs Late Surgical Fenestration for Complications After the Fontan Operation Circulation, July 1, 1997; 96(1): 33 - 36. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |